Dennis, A., Wamil, M., Kapur, S., Alberts, J., Badley, A., Decker, G. A., ... & Banerjee, A. (2020). Multi-organ impairment in low-risk individuals with long COVID. medRxiv. https://www.medrxiv.org/content/10.1101/2020.10.14.20212555v1

Smith College

Google

- Airway expression of SARS-CoV-2 receptor, ACE2, and proteases, TMPRSS2 and furin, in severe asthma
- High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms
- IL-6 signalling pathway inactivation with siltuximab in patients with COVID-19 respiratory failure: an observational cohort study
- Multi-organ impairment in low-risk individuals with long COVID.

MedRxiv Papers Related to COVID-19 Human Physiology

Kermani, N., Song, W. J., Lunt, A., Badi, Y., Versi, A., Yike, G. U. O., ... & Sterk, P. (2020). Airway expression of SARS-CoV-2 receptor, ACE2, and proteases, TMPRSS2 and furin, in severe asthma. medRxiv.
https://www.medrxiv.org/content/10.1101/2020.06.29.20142091v1

Airway expression of SARS-CoV-2 receptor, ACE2, and proteases, TMPRSS2 and furin, in severe asthma

Franke, Christiana, et al. "High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms." medRxiv (2020). doi:10.1101/2020.07.01.20143214 https://www.medrxiv.org/content/10.1101/2020.07.01.20143214v1.full.pdf

High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients
with neurological symptoms

Gritti, G., Raimondi, F., Ripamonti, D., Riva, I., Landi, F., Alborghetti, L., ... & Rambaldi, A. (2020). IL-6 signalling pathway inactivation with siltuximab in patients with COVID-19 respiratory failure: an observational cohort study. https://www.medrxiv.org/content/10.1101/2020.04.01.20048561v4

Learn Before

Related